Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kalaycio

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2001
United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemiaS L Soignet, S R Frankel, D Douer, et al.
Bone Marrow Transplantation|October 19, 2004
Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infectionR K Avery, B J Bolwell, B Yen-Lieberman, et al.
Leukemia|November 7, 2017
Risk of developing chronic myeloid neoplasms in well-differentiated thyroid cancer patients treated with radioactive iodineR J Molenaar, C Pleyer, T Radivoyevitch, et al.
Bone Marrow Transplantation|September 5, 2017
Impact of cigarette smoking on survival after myeloablative allogeneic hematopoietic stem cell transplantation and contribution of invasive fungal infectionA Mehdi, L Rybicki, S Mossad, et al.
Bone Marrow Transplantation|January 16, 2008
Influence of killer immunoglobulin-like receptor/HLA ligand matching on achievement of T-cell complete donor chimerism in related donor nonmyeloablative allogeneic hematopoietic stem cell transplantationR M Sobecks, E J Ball, M Askar, et al.
Bone Marrow Transplantation|June 29, 2000
Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin's lymphomaE A Copelan, S L Penza, B Pohlman, et al.
Leukemia|September 19, 2013
Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasmsF Traina, V Visconte, P Elson, et al.
Bone Marrow Transplantation|April 2, 2025
Influence of pre-transplant estimated glomerular filtration rate (eGFR) on clinical outcomes after allogeneic hematopoietic cell transplantationD P Nurse, H Li, D Cenin, et al.
Blood Cancer Journal|March 12, 2016
Lenalidomide treatment and prognostic markers in relapsed or refractory chronic lymphocytic leukemia: data from the prospective, multicenter phase-II CLL-009 trialA Bühler, C-M Wendtner, T J Kipps, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2001
United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemiaS L Soignet, S R Frankel, D Douer, et al.
Bone Marrow Transplantation|October 19, 2004
Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infectionR K Avery, B J Bolwell, B Yen-Lieberman, et al.
Leukemia|November 7, 2017
Risk of developing chronic myeloid neoplasms in well-differentiated thyroid cancer patients treated with radioactive iodineR J Molenaar, C Pleyer, T Radivoyevitch, et al.
Bone Marrow Transplantation|September 5, 2017
Impact of cigarette smoking on survival after myeloablative allogeneic hematopoietic stem cell transplantation and contribution of invasive fungal infectionA Mehdi, L Rybicki, S Mossad, et al.
Bone Marrow Transplantation|January 16, 2008
Influence of killer immunoglobulin-like receptor/HLA ligand matching on achievement of T-cell complete donor chimerism in related donor nonmyeloablative allogeneic hematopoietic stem cell transplantationR M Sobecks, E J Ball, M Askar, et al.
Bone Marrow Transplantation|June 29, 2000
Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin's lymphomaE A Copelan, S L Penza, B Pohlman, et al.
Leukemia|September 19, 2013
Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasmsF Traina, V Visconte, P Elson, et al.
Bone Marrow Transplantation|April 2, 2025
Influence of pre-transplant estimated glomerular filtration rate (eGFR) on clinical outcomes after allogeneic hematopoietic cell transplantationD P Nurse, H Li, D Cenin, et al.
Blood Cancer Journal|March 12, 2016
Lenalidomide treatment and prognostic markers in relapsed or refractory chronic lymphocytic leukemia: data from the prospective, multicenter phase-II CLL-009 trialA Bühler, C-M Wendtner, T J Kipps, et al.
Pageof 7